| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Apr―04 |
Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning |
Teena Bajaj, Babak Mosavati, Lydia H. Zhang, Mohammad S. Parsa, Huanchen Wang, Evan M. Kerek, Xueying Liang, Seyed Amir Tabatabaei Dakhili, Eddie Wehri, Silin Guo, Rushil N. Desai, Lauren M. Orr, Mohammad R. K. Mofrad, Julia Schaletzky, John R. Ussher, Xufang Deng, Robin Stanley, Basil P. Hubbard, Daniel K. Nomura, Niren Murthy |
| 2 |
[GO] |
2025―Feb―26 |
Dihydropyrimidine-2-thione derivatives as SARS-CoV-2 main protease inhibitors: synthesis, SAR and in vitro profiling |
Anees Saeed, Ayesha Tahir, Muhammad Shah, Fahad Hussain, Abdul Sadiq, Umer Rashid |
| 3 |
[GO] |
2025―Jan―22 |
An integrated theoretical study on natural alkaloids as SARS-CoV-2 main protease inhibitors: a step toward discovery of potential drug candidates with anti-COVID-19 activity |
Shagufta Parveen, Laiba Shahbaz, Nusrat Shafiq, Maryam Rashid, Mohamed Mohany, Mingkun Zhu |
| 4 |
[GO] |
2024―Dez―09 |
Biological and computational assessments of thiazole derivative-reinforced bile salt enriched nano carriers: a new gate in targeting SARS-CoV-2 spike protein |
Mohamed Y. Zakaria, Ayman Abo Elmaaty, Rabeh El-Shesheny, Radwan Alnajjar, Omnia Kutkat, Sana Ben Moussa, Abdullah Yahya Abdullah Alzahrani, Sally A. El-Zahaby, Ahmed A. Al-Karmalawy |
| 5 |
[GO] |
2024―Nov―22 |
Establishment of a Raman microsphere-based immunochromatographic method for the combined detection of influenza A and B viruses and SARS-CoV-2 antigen on a single T-line |
Aolin Zhu, Binbin Zhao, Jiutong Li, Xinxia Li, Qian Shi, Xin Zhang, Dongmei Lu, Dong Yan |
| 6 |
[GO] |
2024―Nov―08 |
Retraction: Fabrication of novel quantum dots for the estimation of COVID-19 antiviral drug using green chemistry: application to real human plasma |
Baher I. Salman, Adel Ehab Ibrahim, Sami El Deeb, Roshdy E. Saraya |
| 7 |
[GO] |
2024―Okt―24 |
Discovery of a novel benzimidazole conjugated quinazolinone derivative as a promising SARS-CoV-2 3CL protease inhibitor |
Bui Thi Buu Hue, Huynh Nguyet Huong Giang, Cuong Quoc Nguyen, Feng-Pai Chou, Danh La Duc Thanh, Quang De Tran, Vo Trung Hieu, Lam Hoang Phuong Mai, Hong-Cheu Lin, Tung-Kung Wu |
| 8 |
[GO] |
2024―Sep―18 |
Identification of lead inhibitors for 3CLpro of SARS-CoV-2 target using machine learning based virtual screening, ADMET analysis, molecular docking and molecular dynamics simulations |
Sandeep Poudel Chhetri, Vishal Singh Bhandari, Rajesh Maharjan, Tika Ram Lamichhane |
| 9 |
[GO] |
2024―Sep―13 |
Design and synthesis of novel main protease inhibitors of COVID-19: quinoxalino[2,1-b]quinazolin-12-ones |
Atefeh Tirehdast, Seddigheh Sheikhi-Mohammareh, Hossein Sabet-Sarvestani, Michael G. Organ, Volodymyr Semeniuchenko, Ali Shiri |
| 10 |
[GO] |
2024―Sep―02 |
Antiviral activity of pyrazole derivatives bearing a hydroxyquinoline scaffold against SARS-CoV-2, HCoV-229E, MERS-CoV, and IBV propagation |
Alaa R. I. Morsy, Sara H. Mahmoud, Noura M. Abou Shama, Walaa Arafa, Gehad A. Yousef, Ahmed. A. Khalil, Sayed K. Ramadan |
| 11 |
[GO] |
2024―Aug―27 |
Artificial intelligence-aiding lab-on-a-chip workforce designed oral [3.1.0] bi and [4.2.0] tricyclic catalytic interceptors inhibiting multiple SARS-CoV-2 protomers assisted by double-shell deep learning |
Surachate Kalasin, Werasak Surareungchai |
| 12 |
[GO] |
2024―Apr―23 |
Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation |
Sanadelaslam S. A. El-Hddad, Mohamed H. Sobhy, Ahmed El-morsy, Nabil A. Shoman, Khaled El-Adl |
| 13 |
[GO] |
2024―Apr―16 |
Detection of SARS-CoV-2 N protein using AgNPs-modified aligned silicon nanowires BioSERS chip |
Sadok Kouz, Amal Raouafi, Awatef Ouhibi, Nathalie Lorrain, Makram Essafi, Manel Mejri, Noureddine Raouafi, Adel Moadhen, Mohammed Guendouz |
| 14 |
[GO] |
2024―Feb―21 |
Naphthoquinone derivatives as potential immunomodulators: prospective for COVID-19 treatment |
Vitor Tassara Moraes, Franco Jazon Caires, Pedro V. da Silva-Neto, Jacqueline Nakau Mendonça, Thais F. C. Fraga-Silva, Bianca Bueno Fontanezi, Priscyla Daniely Marcato, Vania Luiza Deperon Bonato, Carlos Arterio Sorgi, Luiz Alberto Beraldo Moraes, Giuliano Cesar Clososki |
| 15 |
[GO] |
2023―Dez―06 |
Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2 |
Larysa V. Yevsieieva, Kateryna O. Lohachova, Alexander Kyrychenko, Sergiy M. Kovalenko, Volodymyr V. Ivanov, Oleg N. Kalugin |
| 16 |
[GO] |
2023―Nov―22 |
Unsupervised deep learning for molecular dynamics simulations: a novel analysis of protein-ligand interactions in SARS-CoV-2 Mpro |
Jessica Mustali, Ikki Yasuda, Yoshinori Hirano, Kenji Yasuoka, Alfonso Gautieri, Noriyoshi Arai |
| 17 |
[GO] |
2023―Sep―11 |
Bio-conjugated nanoarchitectonics with dual-labeled nanoparticles for a colorimetric and fluorescent dual-mode serological lateral flow immunoassay sensor in detection of SARS-CoV-2 in clinical samples |
Sang Ki Kim, Jong Uk Lee, Myeong Jin Jeon, Soo-Kyung Kim, Sang-Hyun Hwang, Min Eui Hong, Sang Jun Sim |
| 18 |
[GO] |
2023―Jun―13 |
Nano-biosensor for SARS-CoV-2/COVID-19 detection: methods, mechanism and interface design |
Yansheng Liu, Zhenle Qin, Jin Zhou, Xiaobo Jia, Hongli Li, Xiaohong Wang, Yating Chen, Zijun Sun, Xiong He, Hongda Li, Guofu Wang, Haixin Chang |
| 19 |
[GO] |
2023―Jun―12 |
Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication |
Teena Bajaj, Eddie Wehri, Rahul K. Suryawanshi, Elizabeth King, Kundan Singh Pardeshi, Kamyar Behrouzi, Zahra Khodabakhshi, Ursula Schulze-Gahmen, G. Renuka Kumar, Mohammad R. K. Mofrad, Daniel K. Nomura, Melanie Ott, Julia Schaletzky, Niren Murthy |
| 20 |
[GO] |
2023―Jun―06 |
Study of fusion peptide release for the spike protein of SARS-CoV-2 |
Jie Yu, Zhi-Wei Zhang, Han-Yu Yang, Chong-Jin Liu, Wen-Cai Lu |
| 21 |
[GO] |
2023―Mai―19 |
Development of high affinity broadly reactive aptamers for spike protein of multiple SARS-CoV-2 variants |
Thao T. Le, Donald J. Benton, Antoni G. Wrobel, Steven J. Gamblin |
| 22 |
[GO] |
2023―Apr―20 |
Implication of nanotechnology to reduce the environmental risks of waste associated with the COVID-19 pandemic |
Gharieb S. El-Sayyad, Dounia Elfadil, Mohamed S. Gaballah, Dina M. El-Sherif, Mohamed Abouzid, Hanady G. Nada, Mohamed S. Khalil, Mohamed A. Ghorab |
| 23 |
[GO] |
2023―Apr―12 |
Efficient dispersive solid-phase extraction of methylprednisolone from exhaled breath of COVID-19 patients |
Yasaman Sefid-Sefidehkhan, Mehdi Mokhtari, Ata Mahmoodpoor, Yosra Vaez-Gharamaleki, Maryam Khoubnasabjafari, Mohammad Reza Afshar Moghaddam, Vahid Jouyban-Gharamaleki, Siavoush Dastmalchi, Elaheh Rahimpour, Abolghasem Jouyban |
| 24 |
[GO] |
2023―Apr―04 |
A covalent inhibitor targeting the papain-like protease from SARS-CoV-2 inhibits viral replication |
Hesong Han, Albert Vallejo Gracia, Joachim J. Røise, Lydia Boike, Kristoffer Leon, Ursula Schulze-Gahmen, Michael R. Stentzel, Teena Bajaj, Dake Chen, I.-Che Li, Maomao He, Kamyar Behrouzi, Zahra Khodabakhshi, Daniel K. Nomura, Mohammad R. K. Mofrad, G. Renuka Kumar, Melanie Ott, Niren Murthy |
| 25 |
[GO] |
2023―Mrz―28 |
The influence of single-point mutation D614G on the binding process between human angiotensin-converting enzyme 2 and the SARS-CoV-2 spike protein-an atomistic simulation study |
Chengcheng Shi, Yanqi Jiao, Chao Yang, Yao Sun |
| 26 |
[GO] |
2023―Mrz―20 |
Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2 |
Kohei Tsuji, Kofi Baffour-Awuah Owusu, Yutaro Miura, Takahiro Ishii, Kouki Shinohara, Takuya Kobayakawa, Akino Emi, Takashi Nakano, Youichi Suzuki, Hirokazu Tamamura |
| 27 |
[GO] |
2023―Feb―16 |
CeO2@NH2 functionalized electrodes for the rapid detection of SARS-CoV-2 spike receptor binding domain |
Ayu Triastuti, Salma Nur Zakiyyah, Shabarni Gaffar, Isa Anshori, Akhmadi Surawijaya, Darmawan Hidayat, Hesti Lina Wiraswati, Muhammad Yusuf, Yeni Wahyuni Hartati |
| 28 |
[GO] |
2023―Jan―26 |
Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2 |
Sumit Kumar, Brijesh Rathi |
| 29 |
[GO] |
2022―Dez―15 |
Correction: Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations |
Minh Quan Pham, Khanh B. Vu, T. Ngoc Han Pham, Le Thi Thuy Huong, Linh Hoang Tran, Nguyen Thanh Tung, Van V. Vu, Trung Hai Nguyen, Son Tung Ngo |
| 30 |
[GO] |
2022―Dez―06 |
Two-stage one-pot synthetic strategy for the key triazone-triazole intermediate of ensitrelvir (S-217622), an oral clinical candidate for treating COVID-19 |
Wei Hu, Xiang Zhang, Yuanchang Liu, Teng Liu, Jiale Wen, Xiaopeng Peng, Xin Xie, Weiming Chen |
| 31 |
[GO] |
2022―Nov―16 |
Evaluation of antiviral activity of Carica papaya leaves against SARS-CoV-2 assisted by metabolomic profiling |
Amr Adel, Mohamed S. Elnaggar, Amgad Albohy, Ahmed A. Elrashedy, Ahmed Mostafa, Omnia Kutkat, Usama Ramadan Abdelmohsen, Eman Al-Sayed, Mohamed A. Rabeh |
| 32 |
[GO] |
2022―Nov―04 |
Nanotechnology meets immunology towards a rapid diagnosis solution: the COVID-19 outbreak challenge |
Santos B. S. A. S., Cunha J. L. R., Carvalho I. C., Costa J. M. C., Longo B. C., Galinari G. C. F., Diniz P. H. S. M., Mendes G. M. M., Fonseca F. G., Abrahão J. S., Mansur A. A. P., Leite M. F., Oréfice R. L., Lobato Z. I. P., Mansur H. S. |
| 33 |
[GO] |
2022―Nov―02 |
Correction: The role of electrochemical biosensors in SARS-CoV-2 detection: a bibliometrics-based analysis and review |
Shuduan Mao, Li Fu, Chengliang Yin, Xiaozhu Liu, Hassan Karimi-Maleh |
| 34 |
[GO] |
2022―Sep―22 |
In vitro and computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-MPro inhibitors |
Ateyatallah Aljuhani, Hany E. A. Ahmed, Saleh K. Ihmaid, Abdelsattar M. Omar, Sultan S. Althagfan, Yaser M. Alahmadi, Iqrar Ahmad, Harun Patel, Sahar Ahmed, Mohannad A. Almikhlafi, Ahmed M. El-Agrody, Mohamed F. Zayed, Safaa Abdulrahman Turkistani, Shorouk H. Abulkhair, Mohammed Almaghrabi, Samir A. Salama, Ahmed A. Al-Karmalawy, Hamada S. Abulkhair |
| 35 |
[GO] |
2022―Aug―31 |
Salivary SARS-CoV-2 antibody detection using S1-RBD protein-immobilized 3D melt electrowritten poly(ε-caprolactone) scaffolds |
Pingping Han, Chun Liu, Reuben Staples, Corey S. Moran, Srinivas Sulugodu Ramachandra, Maria Natividad Gómez-Cerezo, Sašo Ivanovski |
| 36 |
[GO] |
2022―Aug―12 |
The role of electrochemical biosensors in SARS-CoV-2 detection: a bibliometrics-based analysis and review |
Shudan Mao, Li Fu, Chengliang Yin, Xiaozhu Liu, Hassan Karimi-Maleh |
| 37 |
[GO] |
2022―Aug―11 |
Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement |
Mohamed A. Said, Amgad Albohy, Mohamed A. Abdelrahman, Hany S. Ibarhim |
| 38 |
[GO] |
2022―Aug―09 |
Utility of a novel turn-off fluorescence probe for the determination of tranilast, an adjunctive drug for patients with severe COVID-19 |
Diaa Dagher, Heba Elmansi, Jenny Jeehan Nasr, Nahed El-Enany |
| 39 |
[GO] |
2022―Jul―08 |
Synthesis of pyrazolo[5′,1′:2,3]imidazo[1,5-c]quinazolin-6(5H)-ones and molecular docking study of their affinity against the COVID-19 main protease |
Shaghayegh Saeedi, Abbas Rahmati, Zahra Chavoshpour-Natanzi |
| 40 |
[GO] |
2022―Jul―06 |
Secondary metabolites of Livistona decipiens as potential inhibitors of SARS-CoV-2 |
Seham S. El-hawary, Taha F. S. Ali, Sara O. Abo El-Ela, Ahlam Elwekeel, Usama Ramadan Abdelmohsen, Asmaa I. Owis |
| 41 |
[GO] |
2022―Jun―22 |
In vitro and in silico studies of SARS-CoV-2 main protease Mpro inhibitors isolated from Helichrysum bracteatum |
Gehad Abdel Wahab, Walaa S. Aboelmaaty, Mohamed Farid Lahloub, Amal Sallam |
| 42 |
[GO] |
2022―Jun―22 |
A SARS-Cov-2 sensor based on upconversion nanoparticles and graphene oxide |
Konstantina Alexaki, Maria Eleni Kyriazi, Joshua Greening, Lapatrada Taemaitree, Afaf H. El-Sagheer, Tom Brown, Xunli Zhang, Otto L. Muskens, Antonios G. Kanaras |
| 43 |
[GO] |
2022―Jun―06 |
Fabrication of novel quantum dots for the estimation of COVID-19 antiviral drug using green chemistry: application to real human plasma |
Baher I. Salman, Adel Ehab Ibrahim, Sami El Deeb, Roshdy E. Saraya |
| 44 |
[GO] |
2022―Mai―31 |
Inhibition of SARS-CoV-2 spike protein entry using biologically modified polyacrylonitrile nanofibers: in vitro study towards specific antiviral masks |
Merna H. Emam, Hassan Nageh, Fedaa Ali, Mohamed Taha, Hasnaa A. ElShehaby, Rehab Amin, Elbadawy A. Kamoun, Samah A. Loutfy, Amal Kasry |
| 45 |
[GO] |
2022―Mai―27 |
Pyrazolone-type compounds: synthesis and in silico assessment of antiviral potential against key viral proteins of SARS-CoV-2 |
Jovica Branković, Vesna M. Milovanović, Dušica Simijonović, Slađana Novaković, Zorica D. Petrović, Snežana S. Trifunović, Goran A. Bogdanović, Vladimir P. Petrović |
| 46 |
[GO] |
2022―Mai―25 |
Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil-CNPs) against SARS-CoV-2 (in silico and in vitro study) |
Samah A. Loutfy, Ahmed I. Abdel-Salam, Yassmin Moatasim, Mokhtar R. Gomaa, Nasra F. Abdel Fattah, Merna H. Emam, Fedaa Ali, Hasnaa A. ElShehaby, Eman A. Ragab, Hanaa M. Alam El-Din, Ahmed Mostafa, Mohamed A. Ali, Amal Kasry |
| 47 |
[GO] |
2022―Mai―11 |
A new insight into the transfer and delivery of anti-SARS-CoV-2 drug Carmofur with the assistance of graphene oxide quantum dot as a highly efficient nanovector toward COVID-19 by molecular dynamics simulation |
Mahnaz Shahabi, Heidar Raissi |
| 48 |
[GO] |
2022―Mai―06 |
Green aspects of photocatalysts during corona pandemic: a promising role for the deactivation of COVID-19 virus |
Abhinandan Kumar, Vatika Soni, Pardeep Singh, Aftab Aslam Parwaz Khan, Mohammed Nazim, Satyabrata Mohapatra, Vipin Saini, Pankaj Raizada, Chaudhery Mustansar Hussain, Mohamed Shaban, Hadi M. Marwani, Abdullah M. Asiri |
| 49 |
[GO] |
2022―Mrz―28 |
Rapid diagnosis of COVID-19 via nano-biosensor-implemented biomedical utilization: a systematic review |
Mohammad Harun-Ur-Rashid, Tahmina Foyez, Israt Jahan, Kaushik Pal, Abu Bin Imran |
| 50 |
[GO] |
2022―Mrz―25 |
Cold atmospheric pressure plasma for attenuation of SARS-CoV-2 spike protein binding to ACE2 protein and the RNA deactivation |
Rakesh Ruchel Khanikar, Monalisa Kalita, Parismita Kalita, Bhaswati Kashyap, Santanu Das, Mojibur R. Khan, Heremba Bailung, Kamatchi Sankaranarayanan |
| 51 |
[GO] |
2022―Mrz―23 |
Gate-all-around junctionless FET based label-free dielectric/charge modulation detection of SARS-CoV-2 virus |
Kumari Nibha Priyadarshani, Sangeeta Singh, Mustafa K. A. Mohammed |
| 52 |
[GO] |
2022―Mrz―10 |
Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics |
Farah Anjum, Md Nayab Sulaimani, Alaa Shafie, Taj Mohammad, Ghulam Md. Ashraf, Anwar L. Bilgrami, Fahad A. Alhumaydhi, Suliman A. Alsagaby, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan |
| 53 |
[GO] |
2022―Feb―16 |
Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal |
Prateek Kumar, Taniya Bhardwaj, Rajanish Giri |
| 54 |
[GO] |
2022―Feb―14 |
Exploration of plant-derived natural polyphenols toward COVID-19 main protease inhibitors: DFT, molecular docking approach, and molecular dynamics simulations |
Yufei Ma, Yulian Tao, Hanyang Qu, Cuihong Wang, Fei Yan, Xiujun Gao, Meiling Zhang |
| 55 |
[GO] |
2022―Feb―02 |
Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods |
Md. Oliullah Rafi, Khattab Al-Khafaji, Md. Takim Sarker, Tugba Taskin-Tok, Abdus Samad Rana, Md. Shahedur Rahman |
| 56 |
[GO] |
2022―Jan―28 |
Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro |
Son Tung Ngo, Trung Hai Nguyen, Nguyen Thanh Tung, Binh Khanh Mai |
| 57 |
[GO] |
2022―Jan―28 |
Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach |
Kandhan Palanisamy, S. M. Esther Rubavathy, Muthuramalingam Prakash, Ramasamy Thilagavathi, Maryam S. Hosseini-Zare, Chelliah Selvam |
| 58 |
[GO] |
2022―Jan―25 |
A rapid water bath PCR combined with lateral flow assay for the simultaneous detection of SARS-CoV-2 and influenza B virus |
Hong Chen, Yunxiang Wang, Hongjuan Wei, Zhen Rong, Shengqi Wang |
| 59 |
[GO] |
2022―Jan―20 |
Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase |
Abdo A. Elfiky, Hanan A. Mahran, Ibrahim M. Ibrahim, Mohamed N. Ibrahim, Wael M. Elshemey |
| 60 |
[GO] |
2021―Dez―17 |
GC-MS analysis of phytoconstituents from Ruellia prostrata and Senna tora and identification of potential anti-viral activity against SARS-CoV-2 |
Rahat Alam, Raihan Rahman Imon, Md. Enamul Kabir Talukder, Shahina Akhter, Md. Alam Hossain, Foysal Ahammad, Md. Mashiar Rahman |
| 61 |
[GO] |
2021―Dez―10 |
The dolabellane diterpenes as potential inhibitors of the SARS-CoV-2 main protease: molecular insight of the inhibitory mechanism through computational studies |
Nanik Siti Aminah, Muhammad Ikhlas Abdjan, Andika Pramudya Wardana, Alfinda Novi Kristanti, Imam Siswanto, Khusna Arif Rakhman, Yoshiaki Takaya |
| 62 |
[GO] |
2021―Dez―10 |
Design, synthesis and in silico screening of benzoxazole-thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases |
Vijay Sai Krishna Cheerala, Prasanth Ghanta, Sundaresan Chittor Neelakantan |
| 63 |
[GO] |
2021―Dez―03 |
Whole genome sequencing for revealing the point mutations of SARS-CoV-2 genome in Bangladeshi isolates and their structural effects on viral proteins |
Mohammad Uzzal Hossain, Ishtiaque Ahammad, Arittra Bhattacharjee, Zeshan Mahmud Chowdhury, Md. Tabassum Hossain Emon, Keshob Chandra Das, Chaman Ara Keya, Md. Salimullah |
| 64 |
[GO] |
2021―Dez―01 |
In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors |
Samia A. Elseginy, Manal M. Anwar |
| 65 |
[GO] |
2021―Nov―29 |
Searching and designing potential inhibitors for SARS-CoV-2 Mpro from natural sources using atomistic and deep-learning calculations |
Nguyen Minh Tam, Duc-Hung Pham, Dinh Minh Hiep, Phuong-Thao Tran, Duong Tuan Quang, Son Tung Ngo |
| 66 |
[GO] |
2021―Nov―18 |
Identifying the specific-targeted marine cerebrosides against SARS-CoV-2: an integrated computational approach |
Eman Maher Zahran, Ahmed M. Sayed, Miada F. Abdelwahab, Amgad Albohy, Basma S. Abdulrazik, Ayman M. Ibrahim, Gerhard Bringmann, Usama Ramadan Abdelmohsen |
| 67 |
[GO] |
2021―Nov―10 |
Computational methods directed towards drug repurposing for COVID-19: advantages and limitations |
Prem Prakash Sharma, Meenakshi Bansal, Aaftaab Sethi, Lindomar Pena, Vijay Kumar Goel, Maria Grishina, Shubhra Chaturvedi, Dhruv Kumar, Brijesh Rathi |
| 68 |
[GO] |
2021―Nov―10 |
Determination of sodium and potassium ions in patients with SARS-Cov-2 disease by ion-selective electrodes based on polyelectrolyte complexes as a pseudo-liquid contact phase |
Liubov V. Pershina, Andrei R. Grabeklis, Ludmila N. Isankina, Ekaterina V. Skorb, Konstantin G. Nikolaev |
| 69 |
[GO] |
2021―Nov―03 |
β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization |
Mohammed I. A. Hamed, Khaled M. Darwish, Raya Soltane, Amani Chrouda, Ahmed Mostafa, Noura M. Abo Shama, Sameh S. Elhady, Hamada S. Abulkhair, Ahmed E. Khodir, Ayman Abo Elmaaty, Ahmed A. Al-karmalawy |
| 70 |
[GO] |
2021―Nov―01 |
Theoretical insights into the effect of halogenated substituent on the electronic structure and spectroscopic properties of the favipiravir tautomeric forms and its implications for the treatment of COVID-19 |
Letícia Cristina Assis, Alexandre Alves de Castro, João Paulo Almirão de Jesus, Elaine Fontes Ferreira da Cunha, Eugenie Nepovimova, Ondrej Krejcar, Kamil Kuca, Teodorico Castro Ramalho, Felipe de Almeida La Porta |
| 71 |
[GO] |
2021―Okt―25 |
A label-free graphene-based impedimetric biosensor for real-time tracing of the cytokine storm in blood serum; suitable for screening COVID-19 patients |
Mohammad Ali Khayamian, Mohammad Salemizadeh Parizi, Mohammadreza Ghaderinia, Hamed Abadijoo, Shohreh Vanaei, Hossein Simaee, Saeed Abdolhosseini, Shahriar Shalileh, Mahsa Faramarzpour, Vahid Fadaei Naeini, Parisa Hoseinpour, Fatemeh Shojaeian, Fereshteh Abbasvandi, Mohammad Abdolahad |
| 72 |
[GO] |
2021―Okt―14 |
Thermodynamics and kinetics in antibody resistance of the 501Y.V2 SARS-CoV-2 variant |
Son Tung Ngo, Trung Hai Nguyen, Duc-Hung Pham, Nguyen Thanh Tung, Pham Cam Nam |
| 73 |
[GO] |
2021―Okt―13 |
Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening |
Oludare M. Ogunyemi, Gideon A. Gyebi, Ibrahim M. Ibrahim, Charles O. Olaiya, Joshua O. Ocheje, Modupe M. Fabusiwa, Joseph O. Adebayo |
| 74 |
[GO] |
2021―Sep―30 |
Chemical constituents from Limonium tubiflorum and their in silico evaluation as potential antiviral agents against SARS-CoV-2 |
Ahmed R. Hassan, Ibrahim M. Sanad, Ahmed E. Allam, Mohamed E. Abouelela, Ahmed M. Sayed, Shalabia S. Emam, Salah M. El-Kousy, Kuniyoshi Shimizu |
| 75 |
[GO] |
2021―Sep―22 |
Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants |
Nadim Ferdous, Mahjerin Nasrin Reza, Md. Shariful Islam, Md. Tabassum Hossain Emon, A. K. M. Mohiuddin, Mohammad Uzzal Hossain |
| 76 |
[GO] |
2021―Sep―22 |
Investigating the structure-activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors |
Amr El-Demerdash, Ahmed A. Al-Karmalawy, Tarek Mohamed Abdel-Aziz, Sameh S. Elhady, Khaled M. Darwish, Ahmed H. E. Hassan |
| 77 |
[GO] |
2021―Sep―16 |
Bis-indolylation of aldehydes and ketones using silica-supported FeCl3: molecular docking studies of bisindoles by targeting SARS-CoV-2 main protease binding sites |
Barnali Deb, Sudhan Debnath, Ankita Chakraborty, Swapan Majumdar |
| 78 |
[GO] |
2021―Sep―09 |
The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD-ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective |
Abbas Khan, Jianjun Gui, Waqar Ahmad, Inamul Haq, Marukh Shahid, Awais Ahmed Khan, Abdullah Shah, Arsala Khan, Liaqat Ali, Zeeshan Anwar, Muhammad Safdar, Jehad Abubaker, N. Nizam Uddin, Liqiang Cao, Dong-Qing Wei, Anwar Mohammad |
| 79 |
[GO] |
2021―Sep―02 |
Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow |
Dweipayan Goswami |
| 80 |
[GO] |
2021―Aug―03 |
In silico study of the inhibition of SARS-COV-2 viral cell entry by neem tree extracts |
Daniel M. Shadrack, Said A. H. Vuai, Mtabazi G. Sahini, Isaac Onoka |
| 81 |
[GO] |
2021―Aug―02 |
Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19 |
M. Abd Elkodous, S. O. Olojede, Mahmoud Morsi, Gharieb S. El-Sayyad |
| 82 |
[GO] |
2021―Jul―26 |
Detection of SARS-CoV-2 and its S and N proteins using surface enhanced Raman spectroscopy |
John Eder Sanchez, Sierra A. Jaramillo, Erik Settles, J. Jesus Velazquez Salazar, Alexander Lehr, Javier Gonzalez, Carmen Rodríguez Aranda, Hugo R. Navarro-Contreras, Marlee O. Raniere, Maxx Harvey, David M. Wagner, Andrew Koppisch, Robert Kellar, Paul Keim, Miguel Jose Yacaman |
| 83 |
[GO] |
2021―Jul―02 |
Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2 |
José Rogério A. Silva, Hendrik G. Kruger, Fábio A. Molfetta |
| 84 |
[GO] |
2021―Jun―24 |
In silico study of natural compounds from sesame against COVID-19 by targeting Mpro, PLpro and RdRp |
Ahmed E. Allam, Yhiya Amen, Ahmed Ashour, Hamdy K. Assaf, Heba Ali Hassan, Islam M. Abdel-Rahman, Ahmed M. Sayed, Kuniyoshi Shimizu |
| 85 |
[GO] |
2021―Jun―23 |
Potential inhibitors for SARS-CoV-2 Mpro from marine compounds |
Nguyen Minh Tam, Minh Quan Pham, Huy Truong Nguyen, Nam Dao Hong, Nguyen Khoa Hien, Duong Tuan Quang, Huong Thi Thu Phung, Son Tung Ngo |
| 86 |
[GO] |
2021―Jun―09 |
A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2 |
Kannan Damodharan, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Mukesh Doble, Sathiah Thennarasu |
| 87 |
[GO] |
2021―Jun―04 |
Two novel oxetane containing lignans and a new megastigmane from Paronychia arabica and in silico analysis of them as prospective SARS-CoV-2 inhibitors |
Abdelsamed I. Elshamy, Tarik A. Mohamed, Mahmoud A. A. Ibrahim, Mohamed A. M. Atia, Tatsuro Yoneyama, Akemi Umeyama, Mohamed-Elamir F. Hegazy |
| 88 |
[GO] |
2021―Mai―28 |
3D printed chitosan/polycaprolactone scaffold for lung tissue engineering: hope to be useful for COVID-19 studies |
Farnoush Sadat Rezaei, Ayeh Khorshidian, Farzaneh Mahmoudi Beram, Atefeh Derakhshani, Javad Esmaeili, Aboulfazl Barati |
| 89 |
[GO] |
2021―Mai―19 |
Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2 |
Ahmad J. Obaidullah, Mohammed M. Alanazi, Nawaf A. Alsaif, Hussam Albassam, Abdulrahman A. Almehizia, Ali M. Alqahtani, Shafi Mahmud, Saad Ahmed Sami, Talha Bin Emran |
| 90 |
[GO] |
2021―Mai―12 |
A review on potential of natural products in the management of COVID-19 |
Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, Dhritiman Dey, Priyanka Sharma, Ravichandiran Velayutham, Syamal Roy, Dipanjan Ghosh |
| 91 |
[GO] |
2021―Mai―12 |
Computational estimation of potential inhibitors from known drugs against the main protease of SARS-CoV-2 |
Nguyen Minh Tam, Minh Quan Pham, Nguyen Xuan Ha, Pham Cam Nam, Huong Thi Thu Phung |
| 92 |
[GO] |
2021―Mai―10 |
Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay |
Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, Hong Liu, Yalun Li, Tianyuan Wang, Yuxi Wang |
| 93 |
[GO] |
2021―Mai―05 |
Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2 |
Marvin J. Núñez, Bárbara I. Díaz-Eufracio, José L. Medina-Franco, Dionisio A. Olmedo |
| 94 |
[GO] |
2021―Apr―12 |
Flavonoids of Salvadora persica L. (meswak) and its liposomal formulation as a potential inhibitor of SARS-CoV-2 |
Asmaa I. Owis, Marwa S. El-Hawary, Dalia El Amir, Hesham Refaat, Eman Alaaeldin, Omar M. Aly, Mahmoud A. Elrehany, Mohamed S. Kamel |
| 95 |
[GO] |
2021―Apr―07 |
Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach |
Jubie Selvaraj, Shyam Sundar P, Logesh Rajan, Divakar Selvaraj, Dhanabal Palanisamy, Krishnan Namboori PK, Suresh Kumar Mohankumar |
| 96 |
[GO] |
2021―Mrz―25 |
The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study |
Zhimin Wu, Xiaoxue Chen, Weiju Ni, Danshui Zhou, Shanshan Chai, Weile Ye, Zhengpu Zhang, Yuanqiang Guo, Liping Ren, Yu Zeng |
| 97 |
[GO] |
2021―Mrz―24 |
A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases |
Anju Choorakottayil Pushkaran, Prajeesh Nath EN, Anu R. Melge, Rammanohar Puthiyedath, C. Gopi Mohan |
| 98 |
[GO] |
2021―Mrz―09 |
Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study |
Ayman Abo Elmaaty, Radwan Alnajjar, Mohammed I. A. Hamed, Muhammad Khattab, Mohamed M. Khalifa, Ahmed A. Al-Karmalawy |
| 99 |
[GO] |
2021―Feb―25 |
Insight into the origin of SARS-CoV-2 through structural analysis of receptor recognition: a molecular simulation study |
Jixue Sun, Meijiang Liu, Na Yang |
| 100 |
[GO] |
2021―Feb―08 |
A comprehensive review on antimicrobial face masks: an emerging weapon in fighting pandemics |
Gayathri Pullangott, Uthradevi Kannan, Gayathri S., Degala Venkata Kiran, Shihabudheen M. Maliyekkal |
| 101 |
[GO] |
2021―Feb―02 |
Carbon nanotubes for rapid capturing of SARS-COV-2 virus: revealing a mechanistic aspect of binding based on computational studies |
Shivkumar Patel, Amit Kumar Srivastav, Sanjeev K. Gupta, Umesh Kumar, S. K. Mahapatra, P. N. Gajjar, I. Banerjee |
| 102 |
[GO] |
2021―Jan―27 |
Combination of system biology to probe the anti-viral activity of andrographolide and its derivative against COVID-19 |
Pukar Khanal, Yadu Nandan Dey, Rajesh Patil, Rupesh Chikhale, Manish M. Wanjari, Shailendra S. Gurav, B. M. Patil, Bhavana Srivastava, Sudesh N. Gaidhani |
| 103 |
[GO] |
2021―Jan―22 |
Ligand-based design, molecular dynamics and ADMET studies of suggested SARS-CoV-2 Mpro inhibitors |
Nada M. Mohamed, Eslam M. H. Ali, Asmaa M. AboulMagd |
| 104 |
[GO] |
2021―Jan―19 |
In silico design of peptides with binding to the receptor binding domain (RBD) of the SARS-CoV-2 and their utility in bio-sensor development for SARS-CoV-2 detection |
Yogesh Badhe, Rakesh Gupta, Beena Rai |
| 105 |
[GO] |
2021―Jan―15 |
Correction: The inactivation mechanism of chemical disinfection against SARS-CoV-2: from MD and DFT perspectives |
Chunjian Tan, Chenshan Gao, Quan Zhou, Willem Van Driel, Huaiyu Ye, Guoqi Zhang |
| 106 |
[GO] |
2021―Jan―14 |
Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations |
Kazuki Akisawa, Ryo Hatada, Koji Okuwaki, Yuji Mochizuki, Kaori Fukuzawa, Yuto Komeiji, Shigenori Tanaka |
| 107 |
[GO] |
2021―Jan―13 |
Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro |
Nguyen Minh Tam, Pham Cam Nam, Duong Tuan Quang, Nguyen Thanh Tung, Van V. Vu, Son Tung Ngo |
| 108 |
[GO] |
2021―Jan―13 |
Inhibitory activity of quercetin, its metabolite, and standard antiviral drugs towards enzymes essential for SARS-CoV-2: the role of acid-base equilibria |
Žiko B. Milanović, Marko R. Antonijević, Ana D. Amić, Edina H. Avdović, Dušan S. Dimić, Dejan A. Milenković, Zoran S. Marković |
| 109 |
[GO] |
2021―Jan―04 |
Immune response and possible therapeutics in COVID-19 |
Anindya Dutta, Ananya Roy, Laboni Roy, Samit Chattopadhyay, Subhrangsu Chatterjee |
| 110 |
[GO] |
2020―Dez―14 |
Interpretation of SARS-CoV-2 behaviour on different substrates and denaturation of virions using ethanol: an atomic force microscopy study |
Umit Celik, Kubra Celik, Suleyman Celik, Hasan Abayli, Kezban Can Sahna, Şükrü Tonbak, Zulal Asci Toraman, Ahmet Oral |
| 111 |
[GO] |
2020―Dez―07 |
1-Phenyl-N-(benzothiazol-2-yl)methanimine derivatives as Middle East respiratory syndrome coronavirus inhibitors |
Min-Qi Hu, Heng Li, Ying Lin, Ying Zhang, Jie Tang, Jian-Ping Zuo, Li-Fang Yu, Xian-Kun Tong, Wei Tang, Fan Yang |
| 112 |
[GO] |
2020―Nov―26 |
In silico identification of SARS-CoV-2 spike (S) protein-ACE2 complex inhibitors from eight Tecoma species and cultivars analyzed by LC-MS |
Seham S. El Hawary, Amira R. Khattab, Hanan S. Marzouk, Amira S. El Senousy, Mariam G. A. Alex, Omar M. Aly, Mohamed Teleb, Usama Ramadan Abdelmohsen |
| 113 |
[GO] |
2020―Nov―25 |
Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro |
Vishal M. Balaramnavar, Khurshid Ahmad, Mohd Saeed, Irfan Ahmad, Mehnaz Kamal, Talha Jawaid |
| 114 |
[GO] |
2020―Nov―10 |
Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19) |
Simona De Vita, Maria Giovanna Chini, Gianluigi Lauro, Giuseppe Bifulco |
| 115 |
[GO] |
2020―Nov―09 |
Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations |
Son Tung Ngo, Hung Minh Nguyen, Le Thi Thuy Huong, Pham Minh Quan, Vi Khanh Truong, Nguyen Thanh Tung, Van V. Vu |
| 116 |
[GO] |
2020―Nov―06 |
The inactivation mechanism of chemical disinfection against SARS-CoV-2: from MD and DFT perspectives |
Chunjian Tan, Chenshan Gao, Quan Zhou, Willem Van Driel, Huaiyu Ye, Guoqi Zhang |
| 117 |
[GO] |
2020―Nov―04 |
Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease |
Vladimir Frecer, Stanislav Miertus |
| 118 |
[GO] |
2020―Nov―04 |
Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro |
Vishal M. Balaramnavar, Khurshid Ahmad, Mohd Saeed, Irfan Ahmad, Mehnaz Kamal, Talaha Jawed |
| 119 |
[GO] |
2020―Nov―02 |
Amino acid interacting network in the receptor-binding domain of SARS-CoV-2 spike protein |
Puja Adhikari, Wai-Yim Ching |
| 120 |
[GO] |
2020―Nov―01 |
ACE2 as a potential therapeutic target for pandemic COVID-19 |
Bhaswati Chatterjee, Suman S. Thakur |
| 121 |
[GO] |
2020―Okt―15 |
Anti-inflammatory, antiallergic and COVID-19 protease inhibitory activities of phytochemicals from the Jordanian hawksbeard: identification, structure-activity relationships, molecular modeling and impact on its folk medicinal uses |
Sherif S. Ebada, Nariman A. Al-Jawabri, Fadia S. Youssef, Dina H. El-Kashef, Tim-Oliver Knedel, Amgad Albohy, Michal Korinek, Tsong-Long Hwang, Bing-Hung Chen, Guan-Hua Lin, Chia-Yi Lin, Sa'ed M. Aldalaien, Ahmad M. Disi, Christoph Janiak, Peter Proksch |
| 122 |
[GO] |
2020―Okt―13 |
Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study |
Malvi Surti, Mitesh Patel, Mohd Adnan, Afrasim Moin, Syed Amir Ashraf, Arif Jamal Siddiqui, Mejdi Snoussi, Sumukh Deshpande, Mandadi Narsimha Reddy |
| 123 |
[GO] |
2020―Sep―30 |
Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework |
Neeraj Kumar, Damini Sood, Ramesh Chandra |
| 124 |
[GO] |
2020―Sep―23 |
Diagnostic technologies for COVID-19: a review |
Qi Chen, Zhenyun He, Fujing Mao, Hua Pei, Hongmei Cao, Xing Liu |
| 125 |
[GO] |
2020―Sep―23 |
Several coumarin derivatives and their Pd(ii) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach |
Dejan A. Milenković, Dušan S. Dimić, Edina H. Avdović, Zoran S. Marković |
| 126 |
[GO] |
2020―Sep―18 |
Carotane sesquiterpenes from Ferula vesceritensis: in silico analysis as SARS-CoV-2 binding inhibitors |
Tarik A. Mohamed, Abdelsamed I. Elshamy, Mahmoud A. A. Ibrahim, Ammar Zellagui, Mahmoud F. Moustafa, Alaa H. M. Abdelrahman, Shinji Ohta, Paul W. Pare, Mohamed-Elamir F. Hegazy |
| 127 |
[GO] |
2020―Sep―15 |
Quinazoline-Schiff base conjugates: in silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins |
Mostafa A. Mansour, Asmaa M. AboulMagd, Hamdy M. Abdel-Rahman |
| 128 |
[GO] |
2020―Sep―15 |
Automated multiplex nucleic acid tests for rapid detection of SARS-CoV-2, influenza A and B infection with direct reverse-transcription quantitative PCR (dirRT-qPCR) assay in a centrifugal microfluidic platform |
Minghui Ji, Yun Xia, Jacky Fong-Chuen Loo, Lang Li, Ho-Pui Ho, Jianan He, Dayong Gu |
| 129 |
[GO] |
2020―Sep―04 |
Development of a tablet PC-based portable device for colorimetric determination of assays including COVID-19 and other pathogenic microorganisms |
Woo Sik Yoo, Hyung Soo Han, Jung Gon Kim, Kitaek Kang, Hyo-Sung Jeon, Jin-Young Moon, Hyeonmi Park |
| 130 |
[GO] |
2020―Aug―28 |
Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual screening |
Fatma M. Abd El-Mordy, Mohamed M. El-Hamouly, Magda T. Ibrahim, Gehad Abd El-Rheem, Omar M. Aly, Adel M. Abd El-kader, Khayrya A. Youssif, Usama Ramadan Abdelmohsen |
| 131 |
[GO] |
2020―Aug―28 |
Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations |
Minh Quan Pham, Khanh B. Vu, T. Ngoc Han Pham, Le Thi Thuy Huong, Linh Hoang Tran, Nguyen Thanh Tung, Van V. Vu, Trung Hai Nguyen, Son Tung Ngo |
| 132 |
[GO] |
2020―Aug―25 |
Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets |
Dhivya Shanmugarajan, Prabitha P., B. R. Prashantha Kumar, B. Suresh |
| 133 |
[GO] |
2020―Aug―21 |
A density functional theory study on silver and bis-silver complexes with lighter tetrylene: are silver and bis-silver carbenes candidates for SARS-CoV-2 inhibition? Insight from molecular docking simulation |
Thanh Q. Bui, Huynh Thi Phuong Loan, Tran Thi Ai My, Duong Tuan Quang, Bui Thi Phuong Thuy, Vo Duy Nhan, Phan Tu Quy, Pham Van Tat, Duy Quang Dao, Nguyen Tien Trung, Lam K. Huynh, Nguyen Thi Ai Nhung |
| 134 |
[GO] |
2020―Aug―13 |
An in silico perception for newly isolated flavonoids from peach fruit as privileged avenue for a countermeasure outbreak of COVID-19 |
Ahmed E. Allam, Hamdy K. Assaf, Heba Ali Hassan, Kuniyoshi Shimizu, Yaseen A. M. M. Elshaier |
| 135 |
[GO] |
2020―Aug―13 |
Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies |
Aaftaab Sethi, Swetha Sanam, Sharon Munagalasetty, Sivaraman Jayanthi, Mallika Alvala |
| 136 |
[GO] |
2020―Jul―29 |
Targeting severe acute respiratory syndrome-coronavirus (SARS-CoV-1) with structurally diverse inhibitors: a comprehensive review |
Maryam S. Hosseini-Zare, Ramasamy Thilagavathi, Chelliah Selvam |
| 137 |
[GO] |
2020―Jul―28 |
A facile assay for rapid detection of COVID-19 antibodies |
Caixia Liu, Baiping Mao, Vanessa Martinez, Xiaojian Chen, Yanan Li, Lingyun He, Sian Chen, Xiaoling Guo, Xian Shen, Xiandan Bao, Haifa Shen, Stefania Lenna, Pinyi Qian, Lingzhi Wu, Chao Li |
| 138 |
[GO] |
2020―Jul―28 |
An overview of key potential therapeutic strategies for combat in the COVID-19 battle |
Gaurav Das, Surojit Ghosh, Shubham Garg, Satyajit Ghosh, Aniket Jana, Ramkamal Samat, Nabanita Mukherjee, Rajsekhar Roy, Surajit Ghosh |
| 139 |
[GO] |
2020―Jul―27 |
Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses |
Eman Shawky, Ahmed A. Nada, Reham S. Ibrahim |
| 140 |
[GO] |
2020―Jul―17 |
Potential repurposed SARS-CoV-2 (COVID-19) infection drugs |
Gamal El-Din A. Abuo-Rahma, Mamdouh F. A. Mohamed, Tarek S. Ibrahim, Mai E. Shoman, Ebtihal Samir, Rehab M. Abd El-Baky |
| 141 |
[GO] |
2020―Jul―17 |
Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2 |
Shruti Koulgi, Vinod Jani, Mallikarjunachari V. N. Uppuladinne, Uddhavesh Sonavane, Rajendra Joshi |
| 142 |
[GO] |
2020―Jul―01 |
Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease |
Marisa G. Santibáñez-Morán, Edgar López-López, Fernando D. Prieto-Martínez, Norberto Sánchez-Cruz, José L. Medina-Franco |
| 143 |
[GO] |
2020―Jun―19 |
Natural products' role against COVID-19 |
Ananda da Silva Antonio, Larissa Silveira Moreira Wiedemann, Valdir Florêncio Veiga-Junior |
| 144 |
[GO] |
2020―Jun―15 |
Ursolic acid derivatives are potent inhibitors against porcine reproductive and respiratory syndrome virus |
Yang Chen, Hui Li, Li Wu, Mingxin Zhang, Yarou Gao, Heng Wang, Dan Xu, Weisan Chen, Gaopeng Song, Jianxin Chen |
| 145 |
[GO] |
2020―Mai―21 |
Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease |
Asmaa I. Owis, Marwa S. El-Hawary, Dalia El Amir, Omar M. Aly, Usama Ramadan Abdelmohsen, Mohamed S. Kamel |
| 146 |
[GO] |
2020―Apr―21 |
Anti-HIV drug repurposing against SARS-CoV-2 |
Peng Sang, Shu-Hui Tian, Zhao-Hui Meng, Li-Quan Yang |
| 147 |
[GO] |
2020―Apr―07 |
High antiviral activity of mercaptoethane sulfonate functionalized Te/BSA nanostars against arterivirus and coronavirus |
Yanrong Zhou, Xiaohan Jiang, Ting Tong, Liurong Fang, Yuan Wu, Jiangong Liang, Shaobo Xiao |
